Introduction
Zimiplan DSR by Astemax Biotech is an advanced sustained-release capsule combining pantoprazole gastro-resistant pellets with domperidone prolonged-release pellets, offering 24-hour relief from acid reflux and digestive discomfort. This dual-action formula ensures superior efficacy through optimized release technology, produced in WHO-GMP certified facilities for uncompromising quality and ethical standards.
Product Highlights
Zimiplan DSR features pantoprazole 40 mg for potent acid suppression and domperidone 30 mg for enhanced gastric motility in a single, once-daily capsule. The sustained-release design delivers steady therapeutic levels, minimizing fluctuations for better patient outcomes. Ideal for modern lifestyles demanding reliable GI support.
Key Benefits
-
Rapidly neutralizes heartburn, GERD symptoms, and acid regurgitation with prolonged action.
-
Boosts stomach emptying to reduce bloating, nausea, and indigestion effectively.
-
Prevents ulcer recurrence and supports healing of erosive esophagitis through dual synergy.
Quality Standards
Crafted in Astemax’s WHO-GMP certified plants, Zimiplan DSR undergoes rigorous testing for purity, stability, and bioavailability. Ethical marketing focuses on evidence-based claims, prioritizing physician trust and patient safety without hype.
How It Works
Pantoprazole irreversibly blocks proton pumps to cut acid production by over 90%, while domperidone stimulates peristalsis for faster digestion. The prolonged formula ensures intestinal release of pantoprazole and sustained domperidone activity for all-day efficiency.
